Glaukos Cash on Hand 2014-2023 | GKOS

Glaukos cash on hand from 2014 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Glaukos Annual Cash on Hand
(Millions of US $)
2022 $353
2021 $414
2020 $404
2019 $174
2018 $140
2017 $119
2016 $96
2015 $91
2014 $2
2013 $7
Glaukos Quarterly Cash on Hand
(Millions of US $)
2023-03-31 $318
2022-12-31 $353
2022-09-30 $362
2022-06-30 $391
2022-03-31 $415
2021-12-31 $414
2021-09-30 $429
2021-06-30 $419
2021-03-31 $407
2020-12-31 $404
2020-09-30 $388
2020-06-30 $395
2020-03-31 $164
2019-12-31 $174
2019-09-30 $153
2019-06-30 $150
2019-03-31 $145
2018-12-31 $140
2018-09-30 $138
2018-06-30 $120
2018-03-31 $114
2017-12-31 $119
2017-09-30 $109
2017-06-30 $104
2017-03-31 $99
2016-12-31 $96
2016-09-30 $94
2016-06-30 $94
2016-03-31 $88
2015-12-31 $91
2015-09-30 $93
2015-06-30 $104
2015-03-31 $4
2014-12-31 $2
2014-09-30
2014-06-30
2014-03-31
2013-12-31 $7
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.836B $0.283B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.336B 24.71
Edwards Lifesciences (EW) United States $51.668B 34.09
Alcon (ALC) Switzerland $38.531B 34.94
STERIS (STE) Ireland $19.969B 24.66
Fresenius Medical Care AG KGaA (FMS) Germany $12.634B 14.07
Penumbra (PEN) United States $12.021B 766.44
Teleflex (TFX) United States $10.964B 17.62
Globus Medical (GMED) United States $5.519B 25.23
Integer Holdings (ITGR) United States $2.750B 20.81
Paragon 28 (FNA) United States $1.497B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.144B 14.77
Nevro (NVRO) United States $0.982B 0.00
Artivion (AORT) United States $0.604B 369.25